A detailed history of Dimensional Fund Advisors LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 5,137,201 shares of EXEL stock, worth $148 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,137,201
Previous 4,787,364 7.31%
Holding current value
$148 Million
Previous $114 Million 1.61%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$20.34 - $23.73 $7.12 Million - $8.3 Million
349,837 Added 7.31%
5,137,201 $115 Million
Q1 2024

May 10, 2024

BUY
$20.17 - $23.93 $4.58 Million - $5.43 Million
226,847 Added 4.97%
4,787,364 $114 Million
Q4 2023

Feb 07, 2024

SELL
$19.25 - $24.13 $633,787 - $794,456
-32,924 Reduced 0.72%
4,560,517 $109 Million
Q3 2023

Nov 09, 2023

SELL
$19.04 - $22.74 $2.33 Million - $2.78 Million
-122,251 Reduced 2.59%
4,593,441 $100 Million
Q2 2023

Aug 09, 2023

BUY
$18.17 - $20.48 $1.14 Million - $1.29 Million
62,860 Added 1.35%
4,715,692 $90.1 Million
Q1 2023

May 12, 2023

BUY
$16.3 - $19.41 $4.57 Million - $5.44 Million
280,504 Added 6.42%
4,652,832 $90.3 Million
Q4 2022

Feb 09, 2023

BUY
$14.96 - $17.39 $5.04 Million - $5.86 Million
336,879 Added 8.35%
4,372,328 $70.1 Million
Q3 2022

Nov 10, 2022

BUY
$15.68 - $22.27 $4.01 Million - $5.7 Million
255,886 Added 6.77%
4,035,449 $63.3 Million
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $848,176 - $1.13 Million
48,634 Added 1.3%
3,779,563 $78.7 Million
Q1 2022

May 13, 2022

BUY
$17.03 - $22.67 $5.91 Million - $7.87 Million
346,981 Added 10.25%
3,730,929 $84.6 Million
Q4 2021

Feb 09, 2022

BUY
$15.84 - $21.88 $9.25 Million - $12.8 Million
584,112 Added 20.86%
3,383,948 $61.9 Million
Q3 2021

Nov 12, 2021

BUY
$16.3 - $21.14 $10.9 Million - $14.2 Million
671,706 Added 31.56%
2,799,836 $59.2 Million
Q2 2021

Aug 12, 2021

BUY
$17.95 - $25.56 $5,977 - $8,511
333 Added 0.02%
2,128,130 $38.8 Million
Q1 2021

May 14, 2021

SELL
$20.53 - $25.22 $588,903 - $723,435
-28,685 Reduced 1.33%
2,127,797 $48.1 Million
Q4 2020

Feb 25, 2021

BUY
$18.39 - $24.8 $39.7 Million - $53.5 Million
2,156,482 New
2,156,482 $43.3 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $9.25B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.